AEGiS-PRn: 'Hematologic Manifestations of HIV Disease' Educational Program Debuts On-Line: First-of-Its-Kind Program Provides Up-to-the-Minute Information About Critical, Relatively Ignored Area of AIDS Care

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

'Hematologic Manifestations of HIV Disease' Educational Program Debuts On-Line: First-of-Its-Kind Program Provides Up-to-the-Minute Information About Critical, Relatively Ignored Area of AIDS Care

PR Newswire; Tuesday December 16, 11:45 am EST

POTOMAC, Md., Dec. 16 /PRNewswire/ -- Clinical insights and in-depth information about the hematologic manifestations of HIV disease are now available on-line at www.healthcg.com, a cutting-edge medical web site produced by Healthcare Communications Group, L.L.C. (HCG). "Hematologic Manifestations of HIV" is the newest installment in "Clinical Care Options for HIV," HCG's ongoing continuing medical education program. Thanks to an unrestricted educational grant from Ortho Biotech, the new volume is available free on-line to all interested healthcare professionals and consumers.

Written and developed by Alexandra Levine, M.D., Chief, Division of Hematology, University of Southern California School of Medicine, "Hematologic Manifestations of HIV Disease" reviews the pathogenesis of specific hematologic abnormalities associated with HIV disease, clinical evaluation techniques, appropriate therapeutic interventions, and clinical strategies (outlined in a case history).

"Hematology is a critical, but relatively ignored area of HIV/AIDS care," said Dr. Levine. "This module provides a comprehensive review of what we know about this area, to help healthcare professionals and people with AIDS continue to improve the standard of care. And because the annual American Society of Hemotology meeting has just concluded, the release of this program is particularly timely."

At www.healthcg.com physicians, nurses and pharmacists can study the 10 "Clinical Care Options for HIV" modules -- including "Hemtologic Manifestations of HIV" -- and earn CME credits by registering and completing post tests on-line. Other volumes in the "Clinical Care Options for HIV" program include "Women and HIV," "Antiretroviral Therapy" and "PCP/TOXO/HSV Management in HIV."

"Healthcare Communications Group has won a number of awards this year for the quality and content of our on-line HIV/AIDS information," said Jeffrey Drezner, M.D., Ph.D., Managing Member of Healthcare Communications Group. "'Hematologic Manifestations of HIV' is the most recent in a series of cutting-edge modules designed to provide healthcare professionals and consumers with substantive, practical information not available anywhere else."

Print versions of all of "Clinical Care Options for HIV" modules are available by calling 888-473-1066.

The "Clinical Care Options for HIV" programs are developed with collaborative input from a national scientific advisory board, and are jointly sponsored by Healthcare Communications Group, L.L.C. and Medical Education Collaborative (MEC), a non-profit organization which assures compliance with standards set forth by the Accreditation Council for Continuing Medical Education (ACCME) and the American Council on Pharmaceutical Education (ACPE).

Ortho Biotech, a Johnson & Johnson Company, markets PROCRIT(R) (Epoetin alfa) for the anemias associated with cancer chemotherapy and AZT-treated, HIV-infected patients. PROCRIT is also indicated as an alternative to blood transfusion in elective non-cardiac, non-vascular surgery.

SOURCE: Healthcare Communications Group

Copyright (c) 1997/PR NewsWire. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, PR Newswire, 810 Seventh Avenue, New York, NY 10019.
971216
PR971212

Copyright © 1997 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .